Table 5.
Multivariate regression analysis for mortality.
| Mortality Risk | OR | 95% CI | p |
|---|---|---|---|
| By drug resistance features | |||
| 0 drug resistance | 1.66 | 0.94–6.10 | 0.062 |
| 1 drug resistance | 2.95 | 1.26–5.74 | 0.001 |
| 2 drug resistance | 4.03 | 2.02–8.91 | <0.001 |
| ≥3 drug resistance | 6.71 | 1.93–10.16 | <0.001 |
| By pandemic wave | |||
| 1st pandemic wave | 1.98 | 0.91–6.24 | 0.119 |
| 2nd pandemic wave | 3.72 | 1.15–9.70 | <0.001 |
| 3rd pandemic wave | 1.40 | 1.21–4.96 | 0.003 |
| 4th pandemic wave | 3.61 | 1.90–11.27 | <0.001 |
| 5th pandemic wave | 4.08 | 2.12–10.49 | <0.001 |
| 6th pandemic wave | 1.66 | 0.93–5.39 | 0.084 |
| By type of fungal infection | |||
| Candida spp. | 1.43 | 0.85–2.41 | 0.194 |
| Aspergillus spp. | 4.61 | 1.92–13.27 | <0.001 |
| Mucor spp. | 6.08 | 1.82–11.90 | <0.001 |
| Rhizopus spp. | 5.26 | 0.96–6.15 | 0.107 |
OR—Odds ratio; CI—Confidence interval.